Article citationsMore>>
Penel, N., Ray-Coquard, I., Bal-Mahieu, C., Chevreau, C., Le Cesne, A., Italiano, A., Bompas, E., Clisant, S., Baldeyrou, B., Lansiaux, A., Robin, Y.M., Bay, J.O., Piperno-Neumann, S., Blay, J.Y. and Fournier, C. (2014) Low Level of Baseline Circulating VEGF-A Is Associated with Better Outcome in Patients with Vascular Sarcomas Receiving Sorafenib: An Ancillary Study from a Phase II Trial. Targeted Oncology, 9, 273-277.
http://dx.doi.org/10.1007/s11523-013-0299-0
has been cited by the following article:
-
TITLE:
Sorafenib Acts through VEGFR-2 Inhibition in a Metastatic Clear-Cell Sarcoma of the Kidney
AUTHORS:
Tu V. Dao, Thuan V. Tran, Christophe Lebœuf, Morad El-Bouchtaoui, Jérôme Verine, Anne Janin, Guilhem Bousquet
KEYWORDS:
Tyrosine-Kinase Inhibitor, VEGFR2, Metastases, Clear-Cell Sarcoma of the Kidney
JOURNAL NAME:
Journal of Cancer Therapy,
Vol.7 No.7,
July
5,
2016
ABSTRACT: We report here the case of a young patient with metastatic clear-cell
sarcoma of the kidney resistant to standard chemotherapy, and with complete
response under sorafenib treatment. The remarkable response of her tumor to
sorafenib led us to study sorafenib molecular targets in the metastatic tissue.
Background: Biomarkers predicting response to anti-angiogenic tyrosine kinase
inhibitors remain to be identified. Methods and Findings: In this paper, we
studied the molecular targets of sorafenib in the lung metastasis of a kidney
clear-cell sarcoma. In a patient with complete response under sorafenib
treatment, we showed high VEGFR2 expression by tumor endothelial cells from the
lung metastasis. Conclusion: The original mechanistic results that we obtained
using immunostainings and quantitative RT-PCR on laser-microdissected tumor
endothelial cells have a direct application in daily clinical practice:
metastatic tumors with a large angiogenic component should be tested for VEGFRs
expression to consider anti-angiogenic tyrosine kinase inhibitor treatments.
Related Articles:
-
Police Anil Kumar Reddy, Pulagurla Venkata Laxma Reddy, Vutukuri Maitrey Sharma, Basavaraju Srinivas, Valluri Durga Kumari, Machiraju Subrahmanyam
-
Bineta Jho Diagne, Abid Hakima, Ibtissam El Harch, Soumaya Benmaamar, Bahra Nassiba, Bourkhime Hind, Imad Chakri, Maiouak Moncef, Nada Otmani, Mohammed El Abkari, Mohamed Amine Berraho, Samira El Fakir, Nabil Tachfouti
-
Dikima D. Bibelayi, Albert S. Lundemba, Philippe V. Tsalu, Pitchouna I. Kilunga, Jules M. Tshishimbi, Zéphirin G. Yav
-
Shuhan Ren
-
Gilmar Amorim de Sousa, Iris do Céu Clara Costa, Dyego Leandro Bezerra de Souza, Fabia Barbosa de Andrade, Lívia Medeiros Soares Celani, Ranna Santos Pessoa, Marlon César de Souza Filho, Daniel Fernandes Mello de Oliveira, Luana Lopes de Medeiros, Lucila Samara Dantas de Oliveira, Maria Flávia Monteiro